CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer
Maria Grazia Filippone(European Institute of Oncology), Salvatore Pece(University of Milan)
Cited by 43
Related Papers
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
|EMBO Molecular Medicine|2017|44
Aberrant phosphorylation inactivates Numb in breast cancer causing expansion of the stem cell pool
|The Journal of Cell Biology|2022|16
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
|Nature Communications|2024|9
Mechanisms of active wetting and fluidification in epithelial cell collectives
|Nature Materials|2026|2